LigaChem Biosciences Inc. (KOSDAQ:141080)
193,300
+12,600 (6.97%)
At close: Nov 28, 2025
LigaChem Biosciences Market Cap
LigaChem Biosciences has a market cap or net worth of 7.04 trillion as of November 28, 2025. Its market cap has increased by 61.63% in one year.
Market Cap
7.04T
Enterprise Value
6.50T
Revenue
159.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
193,300.00
Market Cap Chart
Since May 10, 2013, LigaChem Biosciences's market cap has increased from 101.00B to 7.04T, an increase of 6,868.94%. That is a compound annual growth rate of 40.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 7.04T | 77.06% |
| Dec 30, 2024 | 3.98T | 117.55% |
| Dec 28, 2023 | 1.83T | 67.21% |
| Dec 29, 2022 | 1.09T | -19.19% |
| Dec 30, 2021 | 1.35T | -18.55% |
| Dec 30, 2020 | 1.66T | 193.27% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.43T |
| Celltrion | 41.00T |
| ALTEOGEN | 27.70T |
| SK Biopharmaceuticals | 11.02T |
| ABL Bio | 9.56T |
| Yuhan | 8.91T |
| Peptron | 7.44T |
| HLB Co., Ltd. | 6.03T |